Answers are grounded in this paper and cite their sources.
Background Hemophilia A, a hereditary bleeding disorder characterized by the deficiency of factor VIII, significantly impacts the quality of life and long-term health outcomes of affected individuals. For children with Hemophilia A, who are already managing a chronic and complex health condition, the presence of subclinical cardiac changes could represent an additional burden and complicate long-term health outcomes. Aims This study aimed to evaluate subclinical cardiac affection in children with hemophilia A on regular factor replacement therapy. Patients and methods This cross-sectional study was conducted on 50 children, divided into two groups: 30 male children with hemophilia A on regular factor replacement therapy and 20 healthy controls. The participants were selected from the Pediatric Department of Tanta University Hospitals over a year, from April 2023 to 2024. Results The majority of patients (83.3%) had a positive family history of hemophilia. All patients (100%) tested negative for inhibitors. The laboratory data revealed that children with hemophilia A exhibited significantly higher urea levels compared with healthy controls. The mean left ventricular fractional shortening and e′/a′ were significantly lower in the patient group compared with the control group. The findings of the current study underscore the importance of comprehensive and regular echocardiographic assessment of left ventricular function in children with hemophilia A. Conclusion Children with hemophilia A on regular factor replacement therapy exhibited some subclinical cardiac affection.
No takes yet. Share an insight, caveat, or question.
Elokel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: